Screening for NAFLD—Current Knowledge and Challenges

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of abnormal liver function tests worldwide, with an estimated prevalence ranging between 19–46% in the general population. Of note, NAFLD is also expected to become a leading cause of end-stage liver disease in the next decades. Give...

Descripción completa

Detalles Bibliográficos
Autores principales: Forlano, Roberta, Sigon, Giordano, Mullish, Benjamin H., Yee, Michael, Manousou, Pinelopi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144613/
https://www.ncbi.nlm.nih.gov/pubmed/37110194
http://dx.doi.org/10.3390/metabo13040536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144613/
https://www.ncbi.nlm.nih.gov/pubmed/37110194
http://dx.doi.org/10.3390/metabo13040536

Ejemplares similares